SLCH Consortium Transitional Year

Topics

• Clostridium difficile and Clostridium perfringens research 156
• Diabetic Foot Ulcer Assessment and Management 8
• Neutropenia and Cancer Infections 8
• Nosocomial Infections in ICU 8
• Cytomegalovirus and herpesvirus research 6
• Diabetes Management and Research 6
• Treatment of Major Depression 6
• Urinary Tract Infections Management 6
• Antimicrobial Resistance in Staphylococcus 5
• Breast Cancer Treatment Studies 5
• Breast Lesions and Carcinomas 5
• Muscle activation and electromyography studies 5

Most cited

1. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults.

   Cell reports · 2022 · 181 citations · Erik Dubberke

2. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.

   The New England journal of medicine · 2022 · 158 citations · Jane Lynch

3. Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 Update.

   Infection control and hospital epidemiology · 2023 · 81 citations · Erik Dubberke

4. The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA).

   Environmental health perspectives · 2024 · 36 citations · William Goodson

5. PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025 · 30 citations · Erik Dubberke

6. Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.

   BMC infectious diseases · 2022 · 73 citations ·